gvtcx

supplier

Novartis Pharmaceuticals UK Ltd

GU167SR combined from 3 published records

as a supplier

72 recorded awards from 19 buyers , between 8 Jan 2018 and 16 Jun 2026.

awards won
72
exclusive
38%
27 sole-winner awards
median award
£700,000
largest
£480.4m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet Belfast Health & Social Care Trust £1,000,000 16 Jun 2026
Transitional Drugs 7 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £16,804,001 3 Jun 2026
TRAMETINIB 2MG TABLETS, 30 tablet, pack Belfast Health & Social Care Trust £270,000 4 May 2026
NHS National Branded Interim - 1 June 2026 shared NHS England £529,090,780 9 Apr 2026
Contract for Netspot (Gallium Ga 68 Dotatate) The Royal Marsden NHS Foundation Trust £316,800 8 Dec 2025
NHS National Framework Agreement for Omalizumab shared NHS England £87,433,000 26 Nov 2025
NHS National Framework for Generics Housekeeping shared NHS England £21,562,716 10 Nov 2025
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection Western Health & Social Care Trust £4,638,166 10 Nov 2025
PRRT (Peptide Receptor Radionuclide Therapy) Belfast Health & Social Care Trust £1,820,000 10 Nov 2025
Transitional Drugs 4 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £137,717 4 Sept 2025
MIDOSTAURIN 25MG CAPSULES Northern Health And Social Care Trust £180,000 12 Aug 2025
ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL shared Northern Health And Social Care Trust £700,000 12 Aug 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 shared NHS England £688,834,174 30 Jul 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 shared NHS England £782,917,972 30 Jul 2025
NHS National Framework for Transition products (Axitinib and Eltrombopag) shared NHS England £52,385,000 15 Jul 2025
Canakinumab Northern Health And Social Care Trust £120,000 3 Jul 2025
MIDOSTAURIN 25MG CAPSULES, 56 capsules Belfast Health & Social Care Trust £300,000 18 Jun 2025
IPTACOPAN HYDROCHLORIDE MONOHYDRATE 200MG CAPSULES, 56 capsules, pack Belfast Health & Social Care Trust £400,000 14 May 2025
Asciminib Tablets, 60 tablet pack, all strengths Belfast Health & Social Care Trust £260,000 13 May 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £1 11 Feb 2021
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020

every contract won by Novartis Pharmaceuticals UK Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Novartis Pharmaceuticals UK Ltd · GU16 7SR 32
Novartis Pharmaceuticals UK Ltd GB-COH 00119006 W12 7FQ 21
Novartis Pharmaceuticals UK Ltd GB-PPON PJTX-5182-QVLR W12 7FQ 19

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works